Features Screener Stocks Charts
Sign In Sign Up

Dr. Reddy's Laboratories Ltd. Cash Flow Statement

NSE:DRREDDY | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.60x

DRREDDY's operating cash flow covered 60% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹18.92B

DRREDDY's free cash flow was ₹18.92B in FY 2025, down 34.8% from FY 2024.

Dividend Coverage

2.8x

DRREDDY's free cash flow covered dividends 2.8x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

59.2%

Capital expenditure was 59.2% of operating cash flow in FY 2025 for DRREDDY, a moderate level of reinvestment.

2-year DRREDDY cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 72.01B 76.80B
Cash flow Operating Activities 45.43B 46.43B
Investments in PPE -16.40B -27.50B
Cash flow Investing Activities -40.28B -58.08B
Dividend Paid -6.65B -6.66B
Cash flow Financing Activities -3.76B 18.91B
Cash at beginning of period 5.78B 7.11B
Cash at end of period 7.11B 14.59B
Free Cash Flow 29.03B 18.92B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025